Evidence map›Paper›PMID 20012999›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2010

The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer.

Aminah Jatoi, Yingwei Qi, Glenda Kendall, Ruoxiang Jiang, Sheila McNallan, Julie Cunningham, Sumithra Mandrekar, Ping Yang

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02802540 (Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Patients With Anorexia Associated With Advanced Lung Cancer), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02802540 phase2 / phase3unknown statusnot on this mapstarted 2014, after this paper: background citation

Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Patients With Anorexia Associated With Advanced Lung Cancer: Randomized Double Blind Clinical Trial

TypeinterventionalSponsorInstituto Nacional de Cancerologia de MexicoRan2014 to 2017Enrolled78ConditionsNon-Small Cell Lung Cancer, Anorexia, Cachexia, Weight LoseArmsNabilone, Placebo
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Biomarkers associated with cancer-related anorexia in lung cancer: a scoping review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  2. Metabolic underpinnings of cancer-related fatigue.American journal of physiology. Endocrinology and metabolism · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Pathophysiology of anorexia in the cancer cachexia syndrome.Journal of cachexia, sarcopenia and muscle · 2015
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Aminah JatoiDivision of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA. jatoi.aminah@mayo.edu
Yingwei Qi
Glenda Kendall
Ruoxiang Jiang
Sheila McNallan
Julie Cunningham
Sumithra Mandrekar
Ping Yang
Mayo Clinic · USMayo Clinic in Florida · USMayo Clinic in Arizona · US

Funding

Genetic Determinants of Lung Cancer SurvivalR01CA084354 · NCI · MAYO CLINIC ROCHESTER · PI YANG, PING · 2001 to 2012
$4.0M
Health and QOL among Long-Term Lung Cancer SurvivorsR01CA115857 · NCI · MAYO CLINIC ROCHESTER · PI YANG, PING · 2006 to 2010
$2.4M
Mentoring and Research in Cancer Palliative CareK24CA131099 · NCI · MAYO CLINIC ROCHESTER · PI JATOI, AMINAH · 2008 to 2012
$873k
NCI NIH HHS K24 CA131099NCI NIH HHS K24CA131099NCI NIH HHS R01 CA084354NCI NIH HHS R01 CA115857PHS HHS R01 84354
6 · The paper itself

Abstract

objectiveThe cancer anorexia/weight loss syndrome commonly occurs in patients with non-small cell lung cancer (NSCLC) and is characterized by loss of weight and appetite as well as diminished survival. The current study explored whether any of 22 single nucleotide polymorphisms (SNPs) of certain previously implicated inflammatory cytokines (interleukin-1 beta, interleukin-1RN, interleukin-6, and tumor necrosis factor) are associated with this syndrome. PATIENTS AND

methodsAll NSCLC patients who had been enrolled in the Mayo Clinic Lung Cancer Cohort, had completed a health-related questionnaire approximately 6 months after enrollment, and had blood drawn were included in this study, thus yielding a sample size of 471 patients.

resultsSixty-six (14%) patients manifested weight loss shortly after diagnosis, and 152 (32%) reported appetite loss. Only tumor necrosis factor alpha rs800629 was associated with anorexia (odds ratio: 0.46; 95% confidence interval: 0.29, 0.72; p < 0.001); patients who were heterozygous and minor homozygous were less likely to suffer anorexia. Otherwise, there were no statistically significant associations between any of the other 21 SNPs and weight loss and/or anorexia. In univariate analyses, weight loss, anorexia, more advanced cancer stage, and interleukin-1 beta rs1143627 were associated with a worse survival, and interleukin-6 rs2069835 was associated with better survival. However, in multivariate analyses, cancer stage and patient age were the only statistically significant predictors of worse survival.

conclusionNo specific SNP was associated with all aspects of the cancer anorexia/weight loss syndrome, but rs800629 may merit further study in cancer-associated anorexia.

Indexed as

AdolescentAdultAgedAged, 80 and overAge FactorsAnorexiaCarcinoma, Non-Small-Cell LungFemaleHumansInterleukinsLung NeoplasmsMaleMiddle AgedMultivariate AnalysisNeoplasm StagingPolymorphism, Single NucleotideInterleukinsTumor Necrosis Factor-alpha

Identifiers

PMID20012999
PMCPMC2944398
OpenAlexW2140708083

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.